Int'l : +1-503-894-6022 | Toll Free : +1-800-792-5285 | help@alliedmarketresearch.com
A10214 | Pages: NA | Charts: NA | Tables: NA |
Microarray analysis is a very important method that uses gene chips which can bind to over a thousand RNAs at a time. These chips are capable of quantifying mRNA from different types of tissues or in individuals under different treatments, with different sets of DNA which mainly varied based on the tissues or treatment which was identified for the disease.
Microarray analysis is considered to be an important tool when it comes to the elucidation of molecular pathways that lie in the downstream of the key transcriptional regulators for the cardiac development and Coronary Heart Disease. Microarray analysis mainly monitors the gene regulation which results due to allelic variation.
Microarray analysis has a very correlative nature and remains one of the most reliable and powerful techniques for the examination of the genetic processes which underlie in the physiological variation.
Pharmaceutical and biotech companies together with governments around the globe are working to address the COVID-19 outbreak, from supporting the development of vaccines to planning for medicines supply chain challenges. Currently, around 115 vaccine candidates and 155 molecules are in the R&D pipeline. Moreover, commonly used drugs such as Hydroxychloroquine have witnessed a dramatic surge in demand for the management of COVID-19. Such high demand for these drugs has presented huge opportunities for manufacturers of COVID-19 management drugs, as many developed countries are short of these drugs. Owing to the demand for vaccine and treatment drugs for COVID-19, the pharmaceutical and biotechnology industry is expected to witness a significant growth in the future.
Owing to such factors, COVID 19 is expected to have a significant impact on the Microarray Analysis market.
DNA microarrays are used for different types of cancer detection and confirmation. The rising frequency of cancer cases all over the globe is the biggest growth factor of the microarray assay market.
This technology is mainly used for the genome mapping process and the sequencing. Moreover, this technology is also used in the diagnosis of genetic disorders and genetic diseases, pharmacogenomic research, drug discovery, forensic applications, and cancer diagnostics. This technology is also used for the immunology research like the relationship between phenotypes and gene expressions, differentiating and activating the immune cells in the body, regulation of immune responses, analysis of the molecular mechanisms of allergy, and immunological pharmacology.
Various microarray platforms are available for testing in the market. All the above factors together have provided a boost to the microassay analysis market’s growth.
On the other hand, the expensive tests and a need for more high tech instruments for the betterment of the market and more accurate results are hampering the growth of the market.
On June 19th, 2018, Merck and HistoCyte Laboratories entered into an agreement that helped them the distribution of the cell line reference products for the immune-histochemistry in the US and other regions.
On June 19th, 2017, PerkinElmer acquired Euroimmun which help them strengthen their position in the microassay analysis portfolio.
On July 7th, 2017, Agilent Technologies launched its new Customer & Technology Center in the city of Waldbronn, Germany.
On November 27th, 2017, Illumina launched a new solutions center on the campus of Genopole which is located in Paris, France.
Research and academic institutes along with pharmaceutical and biotechnology companies, diagnostic laboratories are the major end-users of the Microassay Market, Amongst them, research and academic institutes are the biggest consumers.
Key benefits of the report:
Questions answered in the Microarray Analysis Market research report:
Key Market Segments
Key Market Players
